GlobeNewswire

– SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular …

Rentokil Initial PLC Class Action Shareholder sues Rentokil Initial PLC (RTO) for misleading investors regarding …

BEIJING, Dec. 18, 2024 (GLOBE NEWSWIRE) — The “2024 Beijing Forum on Swift Response to …

NEW ORLEANS, Dec. 17, 2024 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and …

NEW ORLEANS, Dec. 17, 2024 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and …

Los Angeles, Dec. 16, 2024 (GLOBE NEWSWIRE) — Los Angeles, California – Advanced Networks has …

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES …

NEW YORK, Dec. 15, 2024 (GLOBE NEWSWIRE) — Roadzen Inc. (Nasdaq: RDZN), (“Roadzen” or the …

The healthcare analytical testing services market is growing due to rising clinical trials, biosimilar focus, …

NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor …